| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9403190AFR2717495B1 (en) | 1994-03-18 | 1994-03-18 | Recombinant viruses, preparation and use in gene therapy. |
| AU18961/95AAU1896195A (en) | 1994-03-18 | 1995-03-02 | Recombinant adenoviruses coding for acidic fibroblast growth factor (afgf) |
| EP95911370AEP0750675A1 (en) | 1994-03-18 | 1995-03-02 | RECOMBINANT ADENOVIRUSES CODING FOR ACIDIC FIBROBLAST GROWTH FACTOR (aFGF) |
| CA002184409ACA2184409A1 (en) | 1994-03-18 | 1995-03-02 | Recombinant adenoviruses coding for acidic fibroblast growth factor (afgf) |
| PCT/FR1995/000249WO1995025803A1 (en) | 1994-03-18 | 1995-03-02 | RECOMBINANT ADENOVIRUSES CODING FOR ACIDIC FIBROBLAST GROWTH FACTOR (aFGF) |
| JP7524416AJPH09510357A (en) | 1994-03-18 | 1995-03-02 | Recombinant adenovirus encoding acidic fibroblast growth factor (aFGF) |
| IL112993AIL112993A (en) | 1994-03-18 | 1995-03-14 | Recombinant viruses, their preparation and their use in gene therapy |
| ZA952242AZA952242B (en) | 1994-03-18 | 1995-03-17 | Recombinant viruses their preparation and their use in gene therapy |
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9403190AFR2717495B1 (en) | 1994-03-18 | 1994-03-18 | Recombinant viruses, preparation and use in gene therapy. |
| Publication Number | Publication Date |
|---|---|
| FR2717495A1 FR2717495A1 (en) | 1995-09-22 |
| FR2717495B1true FR2717495B1 (en) | 1996-04-12 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR9403190AExpired - Fee RelatedFR2717495B1 (en) | 1994-03-18 | 1994-03-18 | Recombinant viruses, preparation and use in gene therapy. |
| Country | Link |
|---|---|
| EP (1) | EP0750675A1 (en) |
| JP (1) | JPH09510357A (en) |
| AU (1) | AU1896195A (en) |
| CA (1) | CA2184409A1 (en) |
| FR (1) | FR2717495B1 (en) |
| IL (1) | IL112993A (en) |
| WO (1) | WO1995025803A1 (en) |
| ZA (1) | ZA952242B (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3961019B2 (en)* | 1995-02-28 | 2007-08-15 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | Gene transfer mediated angiogenesis therapy |
| US5792453A (en)* | 1995-02-28 | 1998-08-11 | The Regents Of The University Of California | Gene transfer-mediated angiogenesis therapy |
| CA2370404A1 (en)* | 1999-04-26 | 2000-11-02 | Serge Adnot | Use of a recombinant defective adenovirus comprising a nucleic acid encoding an angiogenic factor for treating pulmonary hypertension |
| FR2792531B1 (en)* | 1999-04-26 | 2003-01-31 | Aventis Pharma Sa | USE OF DEFECTIVE RECOMBINANT ADENOVIRUS COMPRISING A NUCLEIC ACID ENCODING AN ANGIOGENIC FACTOR FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION |
| CN100357443C (en)* | 2000-11-27 | 2007-12-26 | 株式会社载体研究所 | Paramyxovirus vector encoding angiogenesis gene and utilization thereof |
| US20070134204A1 (en)* | 2005-12-09 | 2007-06-14 | Henrich Cheng | Method for treating nerve injury and vector construct for the same |
| KR20100134078A (en) | 2008-04-16 | 2010-12-22 | 잇빤 자이단호진 가가쿠오요비겟세이료호겐쿠쇼 | Method for preparing thrombin immobilized bioabsorbable sheet formulation |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2814529B2 (en)* | 1989-03-16 | 1998-10-22 | 味の素株式会社 | Ischemic brain disorder drug |
| IE914393A1 (en)* | 1990-12-18 | 1992-07-01 | Amgen Inc | Analogs of acidic fibroblast growth factor having enhanced¹stability and biological activity |
| WO1993008828A1 (en)* | 1991-11-08 | 1993-05-13 | Syntex-Synergen Neuroscience Joint Venture | Methods for the treatment of neuronal damage associated with ischemia, hypoxia or neurodegeneration |
| FR2688514A1 (en)* | 1992-03-16 | 1993-09-17 | Centre Nat Rech Scient | Defective recombinant adenoviruses expressing cytokines and antitumour drugs containing them |
| ES2312164T3 (en)* | 1992-09-25 | 2009-02-16 | Aventis Pharma S.A. | ADENOVIRUS VECTORS FOR THE TRANSFER OF STRANGE GENES IN CELLS OF THE CENTRAL NERVOUS SYSTEM, PARTICULARLY IN THE BRAIN. |
| FR2704234B1 (en)* | 1993-04-22 | 1995-07-21 | Centre Nat Rech Scient | RECOMBINANT VIRUSES, PREPARATION AND USE IN GENE THERAPY. |
| Publication number | Publication date |
|---|---|
| AU1896195A (en) | 1995-10-09 |
| IL112993A (en) | 2006-09-05 |
| EP0750675A1 (en) | 1997-01-02 |
| ZA952242B (en) | 1996-01-09 |
| FR2717495A1 (en) | 1995-09-22 |
| IL112993A0 (en) | 1995-06-29 |
| WO1995025803A1 (en) | 1995-09-28 |
| JPH09510357A (en) | 1997-10-21 |
| CA2184409A1 (en) | 1995-09-28 |
| Publication | Publication Date | Title |
|---|---|---|
| FR2712603B1 (en) | Recombinant viruses, preparation and use in gene therapy. | |
| FR2716893B1 (en) | Recombinant viruses, their preparation and their therapeutic use. | |
| FR2718150B1 (en) | Recombinant viruses, preparation and use in gene therapy. | |
| FR2712602B1 (en) | Recombinant viruses, preparation and use in gene therapy. | |
| FI971613A7 (en) | Defective adenoviruses comprising a therapeutic gene and an immunoprotective gene | |
| CZ63995A3 (en) | Virus vectors and their use in gene therapy | |
| DK0595436T3 (en) | PORCINT RESPIRATION AND REPRODUCTION DISEASE VIRUS, VACCINES AND VIRAL DNA | |
| EP0710667A3 (en) | Modified oligonucleotides, their preparation and their use | |
| HUP9802217A3 (en) | Recombinant mva virus, and the use thereof | |
| FI962990A7 (en) | Method for producing recombinant adenovirus-associated viruses (AAVs) and uses thereof | |
| AU3824595A (en) | Recombinant negative strand RNA virus expression systems and vaccines | |
| FR2704234B1 (en) | RECOMBINANT VIRUSES, PREPARATION AND USE IN GENE THERAPY. | |
| FI955154L (en) | Viral recombinants and their use in gene therapy | |
| ZA964679B (en) | Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection. | |
| NO971495L (en) | Attenuated viruses and processes for their preparation | |
| FR2717495B1 (en) | Recombinant viruses, preparation and use in gene therapy. | |
| NO974179L (en) | Recombinant viruses expressing lecithin-cholesterol acyltransferase, and its use in gene therapy | |
| FR2717496B1 (en) | Recombinant viruses, preparation and use in gene therapy. | |
| FR2717823B1 (en) | Recombinant viruses, preparation and use in gene therapy. | |
| FR2717497B1 (en) | Recombinant viruses, preparation and use in gene therapy. | |
| NO902248L (en) | PURE-INHIBITING PEPTIDES, THEIR PREPARATION AND USE IN PHARMACEUTICALS. | |
| FR2725213B1 (en) | VIRAL VECTORS AND USE IN GENE THERAPY | |
| FR2726575B1 (en) | RECOMBINANT VIRUSES, PREPARATION AND USE IN GENE THERAPY | |
| FR2718749B1 (en) | Viral vectors and use in gene therapy. | |
| AU1137101A (en) | Recombinant, replication defective celo virus and celo virus dna |
| Date | Code | Title | Description |
|---|---|---|---|
| CD | Change of name or company name | ||
| ST | Notification of lapse | Effective date:20071130 |